Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine
1998 ◽
Vol 34
(12)
◽
pp. 1958-1961
◽
1999 ◽
Vol 37
(10)
◽
1992 ◽
Vol 28
(1)
◽
pp. 105-112
◽
2001 ◽
Vol 39
(5)
◽
2004 ◽
Vol 96
(7)
◽
pp. 558-559
◽